logo medical-news

Medisinske nyheter

Educational funding by logo MSD_HIV

A pooled analysis shows the renal safety of tenofovir alafenamide

An analysis of pooled data from 26 clinical studies suggests that the favourable renal biomarker profile of tenofovir alafenamide versus tenofovir disoproxil fumarate, observed in the individual trials, translates into a lower rate of clinically significant renal events in persons living with HIV
Tjenesten du prøver å få tilgang til er bare tilgjengelig for registrerte brukere. For å fortsette vennligst logg inn eller registrer deg for en gratis konto på Univadis